Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...
A study reveals that women with adverse pregnancy outcomes and their APO-free sisters share elevated cardiovascular disease risks, indicating genetic links.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback